nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—CYP2B6—malignant glioma	0.577	1	CbGaD
Ritonavir—CYP1A2—Carmustine—malignant glioma	0.0807	0.569	CbGbCtD
Ritonavir—CYP3A4—Temozolomide—malignant glioma	0.061	0.43	CbGbCtD
Ritonavir—Cushing's syndrome—Carmustine—malignant glioma	0.00486	0.0279	CcSEcCtD
Ritonavir—Acute leukaemia—Carmustine—malignant glioma	0.00386	0.0221	CcSEcCtD
Ritonavir—Acute leukaemia—Temozolomide—malignant glioma	0.00373	0.0214	CcSEcCtD
Ritonavir—Vasospasm—Carmustine—malignant glioma	0.00323	0.0185	CcSEcCtD
Ritonavir—Personality disorder—Carmustine—malignant glioma	0.00255	0.0146	CcSEcCtD
Ritonavir—Lopinavir—CYP2B6—malignant glioma	0.00239	1	CrCbGaD
Ritonavir—Grand mal convulsion—Carmustine—malignant glioma	0.00232	0.0133	CcSEcCtD
Ritonavir—Interstitial pneumonia—Temozolomide—malignant glioma	0.00221	0.0126	CcSEcCtD
Ritonavir—Cerebral ischaemia—Temozolomide—malignant glioma	0.00221	0.0126	CcSEcCtD
Ritonavir—Faecal incontinence—Carmustine—malignant glioma	0.00219	0.0125	CcSEcCtD
Ritonavir—Faecal incontinence—Temozolomide—malignant glioma	0.00211	0.0121	CcSEcCtD
Ritonavir—Oral candidiasis—Carmustine—malignant glioma	0.00174	0.00996	CcSEcCtD
Ritonavir—Aphasia—Carmustine—malignant glioma	0.0017	0.00975	CcSEcCtD
Ritonavir—Oral candidiasis—Temozolomide—malignant glioma	0.00168	0.00962	CcSEcCtD
Ritonavir—Parosmia—Temozolomide—malignant glioma	0.00165	0.00942	CcSEcCtD
Ritonavir—Aphasia—Temozolomide—malignant glioma	0.00165	0.00942	CcSEcCtD
Ritonavir—Thrombosis—Carmustine—malignant glioma	0.00156	0.00893	CcSEcCtD
Ritonavir—Interstitial lung disease—Carmustine—malignant glioma	0.00156	0.00893	CcSEcCtD
Ritonavir—Myopathy—Temozolomide—malignant glioma	0.00152	0.00871	CcSEcCtD
Ritonavir—Lung disorder—Temozolomide—malignant glioma	0.00151	0.00863	CcSEcCtD
Ritonavir—Interstitial lung disease—Temozolomide—malignant glioma	0.00151	0.00863	CcSEcCtD
Ritonavir—Stupor—Carmustine—malignant glioma	0.00148	0.00847	CcSEcCtD
Ritonavir—Scotoma—Carmustine—malignant glioma	0.00145	0.00833	CcSEcCtD
Ritonavir—Menorrhagia—Temozolomide—malignant glioma	0.00144	0.00826	CcSEcCtD
Ritonavir—Hepatotoxicity—Carmustine—malignant glioma	0.00143	0.00819	CcSEcCtD
Ritonavir—Scotoma—Temozolomide—malignant glioma	0.00141	0.00805	CcSEcCtD
Ritonavir—Hepatotoxicity—Temozolomide—malignant glioma	0.00138	0.00791	CcSEcCtD
Ritonavir—Hyperaesthesia—Temozolomide—malignant glioma	0.00136	0.00779	CcSEcCtD
Ritonavir—Endocrine disorder—Temozolomide—malignant glioma	0.00129	0.00737	CcSEcCtD
Ritonavir—Speech disorder—Carmustine—malignant glioma	0.00128	0.00735	CcSEcCtD
Ritonavir—Liver injury—Temozolomide—malignant glioma	0.00127	0.00726	CcSEcCtD
Ritonavir—Accidental injury—Carmustine—malignant glioma	0.00125	0.00715	CcSEcCtD
Ritonavir—Speech disorder—Temozolomide—malignant glioma	0.00124	0.00711	CcSEcCtD
Ritonavir—Disturbance in attention—Temozolomide—malignant glioma	0.00123	0.00705	CcSEcCtD
Ritonavir—Breast pain—Temozolomide—malignant glioma	0.00122	0.007	CcSEcCtD
Ritonavir—Thinking abnormal—Carmustine—malignant glioma	0.00121	0.00691	CcSEcCtD
Ritonavir—Drug interaction—Carmustine—malignant glioma	0.00119	0.00682	CcSEcCtD
Ritonavir—Gait disturbance—Carmustine—malignant glioma	0.00113	0.00648	CcSEcCtD
Ritonavir—Coordination abnormal—Carmustine—malignant glioma	0.00112	0.00644	CcSEcCtD
Ritonavir—Hearing impaired—Temozolomide—malignant glioma	0.00112	0.00642	CcSEcCtD
Ritonavir—Neck pain—Carmustine—malignant glioma	0.00112	0.0064	CcSEcCtD
Ritonavir—Gait disturbance—Temozolomide—malignant glioma	0.00109	0.00626	CcSEcCtD
Ritonavir—Respiratory failure—Temozolomide—malignant glioma	0.00109	0.00622	CcSEcCtD
Ritonavir—Coordination abnormal—Temozolomide—malignant glioma	0.00109	0.00622	CcSEcCtD
Ritonavir—Vaginal inflammation—Temozolomide—malignant glioma	0.00107	0.00611	CcSEcCtD
Ritonavir—Depressed level of consciousness—Carmustine—malignant glioma	0.00107	0.00611	CcSEcCtD
Ritonavir—Candida infection—Carmustine—malignant glioma	0.00105	0.00604	CcSEcCtD
Ritonavir—Neuropathy—Carmustine—malignant glioma	0.00104	0.00594	CcSEcCtD
Ritonavir—Depressed level of consciousness—Temozolomide—malignant glioma	0.00103	0.0059	CcSEcCtD
Ritonavir—Candida infection—Temozolomide—malignant glioma	0.00102	0.00583	CcSEcCtD
Ritonavir—Coma—Carmustine—malignant glioma	0.00101	0.00578	CcSEcCtD
Ritonavir—Vaginal infection—Temozolomide—malignant glioma	0.00101	0.00577	CcSEcCtD
Ritonavir—Neuropathy—Temozolomide—malignant glioma	0.001	0.00574	CcSEcCtD
Ritonavir—Abnormal vision—Carmustine—malignant glioma	0.000963	0.00552	CcSEcCtD
Ritonavir—Mental disability—Carmustine—malignant glioma	0.000958	0.00549	CcSEcCtD
Ritonavir—Abnormal vision—Temozolomide—malignant glioma	0.000931	0.00533	CcSEcCtD
Ritonavir—Phlebitis—Carmustine—malignant glioma	0.00093	0.00533	CcSEcCtD
Ritonavir—Mental disability—Temozolomide—malignant glioma	0.000926	0.0053	CcSEcCtD
Ritonavir—Diabetes mellitus—Carmustine—malignant glioma	0.000921	0.00528	CcSEcCtD
Ritonavir—Ear pain—Temozolomide—malignant glioma	0.000908	0.0052	CcSEcCtD
Ritonavir—Eye pain—Carmustine—malignant glioma	0.000888	0.00508	CcSEcCtD
Ritonavir—Gastroenteritis—Temozolomide—malignant glioma	0.000874	0.00501	CcSEcCtD
Ritonavir—Injury—Carmustine—malignant glioma	0.000872	0.00499	CcSEcCtD
Ritonavir—Deafness—Temozolomide—malignant glioma	0.000866	0.00496	CcSEcCtD
Ritonavir—Eye pain—Temozolomide—malignant glioma	0.000858	0.00491	CcSEcCtD
Ritonavir—Amnesia—Carmustine—malignant glioma	0.000853	0.00489	CcSEcCtD
Ritonavir—Amnesia—Temozolomide—malignant glioma	0.000824	0.00472	CcSEcCtD
Ritonavir—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000821	0.0047	CcSEcCtD
Ritonavir—Thirst—Temozolomide—malignant glioma	0.000814	0.00466	CcSEcCtD
Ritonavir—Diplopia—Carmustine—malignant glioma	0.000801	0.00459	CcSEcCtD
Ritonavir—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000801	0.00459	CcSEcCtD
Ritonavir—Diplopia—Temozolomide—malignant glioma	0.000775	0.00444	CcSEcCtD
Ritonavir—Face oedema—Carmustine—malignant glioma	0.000774	0.00443	CcSEcCtD
Ritonavir—Affect lability—Temozolomide—malignant glioma	0.000762	0.00437	CcSEcCtD
Ritonavir—Ataxia—Carmustine—malignant glioma	0.000754	0.00432	CcSEcCtD
Ritonavir—Face oedema—Temozolomide—malignant glioma	0.000748	0.00428	CcSEcCtD
Ritonavir—Liver function test abnormal—Carmustine—malignant glioma	0.00074	0.00424	CcSEcCtD
Ritonavir—Mood swings—Temozolomide—malignant glioma	0.000734	0.0042	CcSEcCtD
Ritonavir—Ataxia—Temozolomide—malignant glioma	0.000728	0.00417	CcSEcCtD
Ritonavir—Dehydration—Temozolomide—malignant glioma	0.00072	0.00413	CcSEcCtD
Ritonavir—Dry skin—Temozolomide—malignant glioma	0.00071	0.00407	CcSEcCtD
Ritonavir—Muscular weakness—Carmustine—malignant glioma	0.000707	0.00405	CcSEcCtD
Ritonavir—Breast disorder—Temozolomide—malignant glioma	0.0007	0.00401	CcSEcCtD
Ritonavir—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000697	0.00399	CcSEcCtD
Ritonavir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000697	0.00399	CcSEcCtD
Ritonavir—Dysphagia—Carmustine—malignant glioma	0.000693	0.00397	CcSEcCtD
Ritonavir—Muscular weakness—Temozolomide—malignant glioma	0.000683	0.00391	CcSEcCtD
Ritonavir—Abdominal distension—Temozolomide—malignant glioma	0.000674	0.00386	CcSEcCtD
Ritonavir—Dysphagia—Temozolomide—malignant glioma	0.000669	0.00383	CcSEcCtD
Ritonavir—Neutropenia—Carmustine—malignant glioma	0.000648	0.00371	CcSEcCtD
Ritonavir—Bronchitis—Temozolomide—malignant glioma	0.000644	0.00369	CcSEcCtD
Ritonavir—Neutropenia—Temozolomide—malignant glioma	0.000626	0.00359	CcSEcCtD
Ritonavir—Dysuria—Temozolomide—malignant glioma	0.000626	0.00359	CcSEcCtD
Ritonavir—Hyperglycaemia—Carmustine—malignant glioma	0.000625	0.00358	CcSEcCtD
Ritonavir—Pollakiuria—Temozolomide—malignant glioma	0.000618	0.00354	CcSEcCtD
Ritonavir—Erectile dysfunction—Temozolomide—malignant glioma	0.000617	0.00353	CcSEcCtD
Ritonavir—Depression—Carmustine—malignant glioma	0.000616	0.00353	CcSEcCtD
Ritonavir—Photosensitivity reaction—Temozolomide—malignant glioma	0.000611	0.0035	CcSEcCtD
Ritonavir—Renal failure—Carmustine—malignant glioma	0.000607	0.00348	CcSEcCtD
Ritonavir—Weight decreased—Temozolomide—malignant glioma	0.000606	0.00347	CcSEcCtD
Ritonavir—Neuropathy peripheral—Carmustine—malignant glioma	0.000605	0.00347	CcSEcCtD
Ritonavir—Hyperglycaemia—Temozolomide—malignant glioma	0.000604	0.00346	CcSEcCtD
Ritonavir—Stomatitis—Carmustine—malignant glioma	0.000602	0.00345	CcSEcCtD
Ritonavir—Urinary tract infection—Carmustine—malignant glioma	0.0006	0.00344	CcSEcCtD
Ritonavir—Depression—Temozolomide—malignant glioma	0.000595	0.00341	CcSEcCtD
Ritonavir—Neuropathy peripheral—Temozolomide—malignant glioma	0.000585	0.00335	CcSEcCtD
Ritonavir—Stomatitis—Temozolomide—malignant glioma	0.000582	0.00333	CcSEcCtD
Ritonavir—Urinary tract infection—Temozolomide—malignant glioma	0.00058	0.00332	CcSEcCtD
Ritonavir—Hepatobiliary disease—Temozolomide—malignant glioma	0.000564	0.00323	CcSEcCtD
Ritonavir—Sinusitis—Temozolomide—malignant glioma	0.00056	0.00321	CcSEcCtD
Ritonavir—Haemoglobin—Carmustine—malignant glioma	0.000557	0.00319	CcSEcCtD
Ritonavir—Haemorrhage—Carmustine—malignant glioma	0.000554	0.00318	CcSEcCtD
Ritonavir—Hypoaesthesia—Carmustine—malignant glioma	0.000552	0.00316	CcSEcCtD
Ritonavir—Hallucination—Carmustine—malignant glioma	0.000552	0.00316	CcSEcCtD
Ritonavir—Oedema peripheral—Carmustine—malignant glioma	0.000546	0.00313	CcSEcCtD
Ritonavir—Connective tissue disorder—Carmustine—malignant glioma	0.000545	0.00312	CcSEcCtD
Ritonavir—Haemoglobin—Temozolomide—malignant glioma	0.000539	0.00308	CcSEcCtD
Ritonavir—Haemorrhage—Temozolomide—malignant glioma	0.000536	0.00307	CcSEcCtD
Ritonavir—Hepatitis—Temozolomide—malignant glioma	0.000536	0.00307	CcSEcCtD
Ritonavir—Visual impairment—Carmustine—malignant glioma	0.000534	0.00306	CcSEcCtD
Ritonavir—Hypoaesthesia—Temozolomide—malignant glioma	0.000533	0.00305	CcSEcCtD
Ritonavir—Hallucination—Temozolomide—malignant glioma	0.000533	0.00305	CcSEcCtD
Ritonavir—Pharyngitis—Temozolomide—malignant glioma	0.000532	0.00305	CcSEcCtD
Ritonavir—Urinary tract disorder—Temozolomide—malignant glioma	0.000529	0.00303	CcSEcCtD
Ritonavir—Oedema peripheral—Temozolomide—malignant glioma	0.000528	0.00302	CcSEcCtD
Ritonavir—Connective tissue disorder—Temozolomide—malignant glioma	0.000527	0.00302	CcSEcCtD
Ritonavir—Urethral disorder—Temozolomide—malignant glioma	0.000525	0.00301	CcSEcCtD
Ritonavir—Eye disorder—Carmustine—malignant glioma	0.000518	0.00297	CcSEcCtD
Ritonavir—Visual impairment—Temozolomide—malignant glioma	0.000516	0.00296	CcSEcCtD
Ritonavir—Flushing—Carmustine—malignant glioma	0.000515	0.00295	CcSEcCtD
Ritonavir—Erythema multiforme—Temozolomide—malignant glioma	0.000507	0.0029	CcSEcCtD
Ritonavir—Eye disorder—Temozolomide—malignant glioma	0.000501	0.00287	CcSEcCtD
Ritonavir—Tinnitus—Temozolomide—malignant glioma	0.0005	0.00286	CcSEcCtD
Ritonavir—Flushing—Temozolomide—malignant glioma	0.000497	0.00285	CcSEcCtD
Ritonavir—Cardiac disorder—Temozolomide—malignant glioma	0.000497	0.00285	CcSEcCtD
Ritonavir—Angiopathy—Temozolomide—malignant glioma	0.000486	0.00278	CcSEcCtD
Ritonavir—Mental disorder—Carmustine—malignant glioma	0.000486	0.00278	CcSEcCtD
Ritonavir—Immune system disorder—Temozolomide—malignant glioma	0.000484	0.00277	CcSEcCtD
Ritonavir—Mediastinal disorder—Temozolomide—malignant glioma	0.000483	0.00277	CcSEcCtD
Ritonavir—Malnutrition—Carmustine—malignant glioma	0.000483	0.00276	CcSEcCtD
Ritonavir—Chills—Temozolomide—malignant glioma	0.000481	0.00275	CcSEcCtD
Ritonavir—Mental disorder—Temozolomide—malignant glioma	0.000469	0.00269	CcSEcCtD
Ritonavir—Back pain—Carmustine—malignant glioma	0.000467	0.00267	CcSEcCtD
Ritonavir—Malnutrition—Temozolomide—malignant glioma	0.000466	0.00267	CcSEcCtD
Ritonavir—Dysgeusia—Temozolomide—malignant glioma	0.000457	0.00262	CcSEcCtD
Ritonavir—Vision blurred—Carmustine—malignant glioma	0.000455	0.00261	CcSEcCtD
Ritonavir—Tremor—Carmustine—malignant glioma	0.000452	0.00259	CcSEcCtD
Ritonavir—Back pain—Temozolomide—malignant glioma	0.000451	0.00258	CcSEcCtD
Ritonavir—Anaemia—Carmustine—malignant glioma	0.000446	0.00256	CcSEcCtD
Ritonavir—Agitation—Carmustine—malignant glioma	0.000444	0.00254	CcSEcCtD
Ritonavir—Vision blurred—Temozolomide—malignant glioma	0.00044	0.00252	CcSEcCtD
Ritonavir—Tremor—Temozolomide—malignant glioma	0.000437	0.0025	CcSEcCtD
Ritonavir—Ill-defined disorder—Temozolomide—malignant glioma	0.000433	0.00248	CcSEcCtD
Ritonavir—Leukopenia—Carmustine—malignant glioma	0.000432	0.00247	CcSEcCtD
Ritonavir—Anaemia—Temozolomide—malignant glioma	0.000431	0.00247	CcSEcCtD
Ritonavir—Agitation—Temozolomide—malignant glioma	0.000429	0.00246	CcSEcCtD
Ritonavir—Malaise—Temozolomide—malignant glioma	0.000421	0.00241	CcSEcCtD
Ritonavir—Vertigo—Temozolomide—malignant glioma	0.000419	0.0024	CcSEcCtD
Ritonavir—Convulsion—Carmustine—malignant glioma	0.000418	0.0024	CcSEcCtD
Ritonavir—Leukopenia—Temozolomide—malignant glioma	0.000418	0.00239	CcSEcCtD
Ritonavir—Hypertension—Carmustine—malignant glioma	0.000417	0.00239	CcSEcCtD
Ritonavir—Palpitations—Temozolomide—malignant glioma	0.000412	0.00236	CcSEcCtD
Ritonavir—Myalgia—Carmustine—malignant glioma	0.000411	0.00235	CcSEcCtD
Ritonavir—Chest pain—Carmustine—malignant glioma	0.000411	0.00235	CcSEcCtD
Ritonavir—Anxiety—Carmustine—malignant glioma	0.000409	0.00235	CcSEcCtD
Ritonavir—Cough—Temozolomide—malignant glioma	0.000407	0.00233	CcSEcCtD
Ritonavir—Convulsion—Temozolomide—malignant glioma	0.000404	0.00231	CcSEcCtD
Ritonavir—Hypertension—Temozolomide—malignant glioma	0.000403	0.00231	CcSEcCtD
Ritonavir—Confusional state—Carmustine—malignant glioma	0.000397	0.00227	CcSEcCtD
Ritonavir—Arthralgia—Temozolomide—malignant glioma	0.000397	0.00227	CcSEcCtD
Ritonavir—Myalgia—Temozolomide—malignant glioma	0.000397	0.00227	CcSEcCtD
Ritonavir—Anxiety—Temozolomide—malignant glioma	0.000396	0.00227	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000394	0.00226	CcSEcCtD
Ritonavir—Oedema—Carmustine—malignant glioma	0.000394	0.00226	CcSEcCtD
Ritonavir—Discomfort—Temozolomide—malignant glioma	0.000392	0.00225	CcSEcCtD
Ritonavir—Dry mouth—Temozolomide—malignant glioma	0.000388	0.00222	CcSEcCtD
Ritonavir—Thrombocytopenia—Carmustine—malignant glioma	0.000386	0.00221	CcSEcCtD
Ritonavir—Tachycardia—Carmustine—malignant glioma	0.000384	0.0022	CcSEcCtD
Ritonavir—Confusional state—Temozolomide—malignant glioma	0.000384	0.0022	CcSEcCtD
Ritonavir—Oedema—Temozolomide—malignant glioma	0.000381	0.00218	CcSEcCtD
Ritonavir—Anorexia—Carmustine—malignant glioma	0.000375	0.00215	CcSEcCtD
Ritonavir—Nervous system disorder—Temozolomide—malignant glioma	0.000373	0.00214	CcSEcCtD
Ritonavir—Thrombocytopenia—Temozolomide—malignant glioma	0.000373	0.00213	CcSEcCtD
Ritonavir—Skin disorder—Temozolomide—malignant glioma	0.00037	0.00212	CcSEcCtD
Ritonavir—Hypotension—Carmustine—malignant glioma	0.000368	0.00211	CcSEcCtD
Ritonavir—Hyperhidrosis—Temozolomide—malignant glioma	0.000368	0.00211	CcSEcCtD
Ritonavir—Anorexia—Temozolomide—malignant glioma	0.000363	0.00208	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000359	0.00206	CcSEcCtD
Ritonavir—Insomnia—Carmustine—malignant glioma	0.000356	0.00204	CcSEcCtD
Ritonavir—Paraesthesia—Carmustine—malignant glioma	0.000354	0.00203	CcSEcCtD
Ritonavir—Dyspnoea—Carmustine—malignant glioma	0.000351	0.00201	CcSEcCtD
Ritonavir—Somnolence—Carmustine—malignant glioma	0.00035	0.00201	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000347	0.00199	CcSEcCtD
Ritonavir—Insomnia—Temozolomide—malignant glioma	0.000344	0.00197	CcSEcCtD
Ritonavir—Decreased appetite—Carmustine—malignant glioma	0.000342	0.00196	CcSEcCtD
Ritonavir—Paraesthesia—Temozolomide—malignant glioma	0.000342	0.00196	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00034	0.00195	CcSEcCtD
Ritonavir—Dyspnoea—Temozolomide—malignant glioma	0.000339	0.00194	CcSEcCtD
Ritonavir—Somnolence—Temozolomide—malignant glioma	0.000338	0.00194	CcSEcCtD
Ritonavir—Pain—Carmustine—malignant glioma	0.000337	0.00193	CcSEcCtD
Ritonavir—Constipation—Carmustine—malignant glioma	0.000337	0.00193	CcSEcCtD
Ritonavir—Dyspepsia—Temozolomide—malignant glioma	0.000335	0.00192	CcSEcCtD
Ritonavir—Decreased appetite—Temozolomide—malignant glioma	0.000331	0.0019	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000329	0.00188	CcSEcCtD
Ritonavir—Fatigue—Temozolomide—malignant glioma	0.000328	0.00188	CcSEcCtD
Ritonavir—Constipation—Temozolomide—malignant glioma	0.000326	0.00186	CcSEcCtD
Ritonavir—Pain—Temozolomide—malignant glioma	0.000326	0.00186	CcSEcCtD
Ritonavir—Feeling abnormal—Carmustine—malignant glioma	0.000325	0.00186	CcSEcCtD
Ritonavir—Gastrointestinal pain—Carmustine—malignant glioma	0.000322	0.00184	CcSEcCtD
Ritonavir—Feeling abnormal—Temozolomide—malignant glioma	0.000314	0.0018	CcSEcCtD
Ritonavir—Body temperature increased—Carmustine—malignant glioma	0.000311	0.00178	CcSEcCtD
Ritonavir—Abdominal pain—Carmustine—malignant glioma	0.000311	0.00178	CcSEcCtD
Ritonavir—Gastrointestinal pain—Temozolomide—malignant glioma	0.000311	0.00178	CcSEcCtD
Ritonavir—Urticaria—Temozolomide—malignant glioma	0.000302	0.00173	CcSEcCtD
Ritonavir—Abdominal pain—Temozolomide—malignant glioma	0.000301	0.00172	CcSEcCtD
Ritonavir—Body temperature increased—Temozolomide—malignant glioma	0.000301	0.00172	CcSEcCtD
Ritonavir—Hypersensitivity—Carmustine—malignant glioma	0.00029	0.00166	CcSEcCtD
Ritonavir—Asthenia—Carmustine—malignant glioma	0.000283	0.00162	CcSEcCtD
Ritonavir—Hypersensitivity—Temozolomide—malignant glioma	0.00028	0.00161	CcSEcCtD
Ritonavir—Asthenia—Temozolomide—malignant glioma	0.000273	0.00156	CcSEcCtD
Ritonavir—Diarrhoea—Carmustine—malignant glioma	0.00027	0.00154	CcSEcCtD
Ritonavir—Pruritus—Temozolomide—malignant glioma	0.000269	0.00154	CcSEcCtD
Ritonavir—Dizziness—Carmustine—malignant glioma	0.00026	0.00149	CcSEcCtD
Ritonavir—Diarrhoea—Temozolomide—malignant glioma	0.00026	0.00149	CcSEcCtD
Ritonavir—Dizziness—Temozolomide—malignant glioma	0.000252	0.00144	CcSEcCtD
Ritonavir—Vomiting—Carmustine—malignant glioma	0.00025	0.00143	CcSEcCtD
Ritonavir—Rash—Carmustine—malignant glioma	0.000248	0.00142	CcSEcCtD
Ritonavir—Dermatitis—Carmustine—malignant glioma	0.000248	0.00142	CcSEcCtD
Ritonavir—Headache—Carmustine—malignant glioma	0.000247	0.00141	CcSEcCtD
Ritonavir—Vomiting—Temozolomide—malignant glioma	0.000242	0.00139	CcSEcCtD
Ritonavir—Rash—Temozolomide—malignant glioma	0.00024	0.00137	CcSEcCtD
Ritonavir—Dermatitis—Temozolomide—malignant glioma	0.00024	0.00137	CcSEcCtD
Ritonavir—Headache—Temozolomide—malignant glioma	0.000238	0.00137	CcSEcCtD
Ritonavir—Nausea—Carmustine—malignant glioma	0.000234	0.00134	CcSEcCtD
Ritonavir—Nausea—Temozolomide—malignant glioma	0.000226	0.0013	CcSEcCtD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.28e-05	0.000123	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.28e-05	0.000123	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.28e-05	0.000123	CbGpPWpGaD
Ritonavir—ABCC1—Disease—BRAF—malignant glioma	1.26e-05	0.00012	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PIK3CG—malignant glioma	1.24e-05	0.000119	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—CAV1—malignant glioma	1.23e-05	0.000118	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.23e-05	0.000117	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.22e-05	0.000117	CbGpPWpGaD
Ritonavir—ABCC1—Disease—AKT2—malignant glioma	1.22e-05	0.000117	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PTGS1—malignant glioma	1.21e-05	0.000116	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.21e-05	0.000116	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PPARG—malignant glioma	1.2e-05	0.000115	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.18e-05	0.000113	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PIK3CD—malignant glioma	1.17e-05	0.000113	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.17e-05	0.000112	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—IDH1—malignant glioma	1.17e-05	0.000112	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—CAV1—malignant glioma	1.17e-05	0.000112	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GSTT1—malignant glioma	1.15e-05	0.00011	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—SPHK1—malignant glioma	1.13e-05	0.000109	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GSTT1—malignant glioma	1.12e-05	0.000108	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—BCHE—malignant glioma	1.12e-05	0.000108	CbGpPWpGaD
Ritonavir—ABCC1—Disease—FGF2—malignant glioma	1.12e-05	0.000108	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PIK3CG—malignant glioma	1.12e-05	0.000107	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.12e-05	0.000107	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.11e-05	0.000107	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.11e-05	0.000106	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.11e-05	0.000106	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PIK3CD—malignant glioma	1.09e-05	0.000105	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.09e-05	0.000105	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—CAV1—malignant glioma	1.08e-05	0.000104	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PTGS1—malignant glioma	1.08e-05	0.000104	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PPARG—malignant glioma	1.08e-05	0.000103	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.08e-05	0.000103	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.08e-05	0.000103	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—CAV1—malignant glioma	1.07e-05	0.000103	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PIK3CG—malignant glioma	1.06e-05	0.000102	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GSTT1—malignant glioma	1.06e-05	0.000102	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—GSTP1—malignant glioma	1.06e-05	0.000101	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PTGS1—malignant glioma	1.05e-05	0.000101	CbGpPWpGaD
Ritonavir—ABCC1—Disease—MDM2—malignant glioma	1.05e-05	0.000101	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—IDH2—malignant glioma	1.05e-05	0.000101	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GSTT1—malignant glioma	1.05e-05	0.000101	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.05e-05	0.000101	CbGpPWpGaD
Ritonavir—ABCC1—Disease—RAF1—malignant glioma	1.05e-05	0.0001	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.05e-05	0.0001	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.04e-05	9.98e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—ERBB2—malignant glioma	1.04e-05	9.94e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—GSTP1—malignant glioma	1.04e-05	9.92e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—GSTP1—malignant glioma	1.03e-05	9.9e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CAT—malignant glioma	1.03e-05	9.86e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PPARG—malignant glioma	1.03e-05	9.83e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PIK3CB—malignant glioma	1.02e-05	9.81e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PTGS2—malignant glioma	1.01e-05	9.72e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CAT—malignant glioma	1.01e-05	9.66e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CAT—malignant glioma	1.01e-05	9.64e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—BCHE—malignant glioma	1e-05	9.62e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PTGS1—malignant glioma	9.93e-06	9.52e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.92e-06	9.51e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.88e-06	9.47e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PTGS1—malignant glioma	9.85e-06	9.44e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PIK3CG—malignant glioma	9.84e-06	9.43e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PIK3CD—malignant glioma	9.83e-06	9.42e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.81e-06	9.4e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—BCHE—malignant glioma	9.8e-06	9.39e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PIK3CG—malignant glioma	9.75e-06	9.35e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—NCOR1—malignant glioma	9.71e-06	9.31e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—SLC5A5—malignant glioma	9.68e-06	9.28e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.54e-06	9.14e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PIK3CB—malignant glioma	9.52e-06	9.13e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—NCOR1—malignant glioma	9.51e-06	9.12e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PPARG—malignant glioma	9.5e-06	9.1e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—NCOR1—malignant glioma	9.49e-06	9.1e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PTGS2—malignant glioma	9.44e-06	9.04e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PPARG—malignant glioma	9.41e-06	9.02e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.38e-06	8.99e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PIK3CD—malignant glioma	9.34e-06	8.96e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.29e-06	8.91e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—BCHE—malignant glioma	9.23e-06	8.85e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.2e-06	8.82e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—BCHE—malignant glioma	9.15e-06	8.77e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—SLC5A5—malignant glioma	9.12e-06	8.74e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.08e-06	8.7e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—SLC5A5—malignant glioma	9.04e-06	8.67e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—IDH1—malignant glioma	9.04e-06	8.66e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GSTT1—malignant glioma	8.98e-06	8.61e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GSTP1—malignant glioma	8.95e-06	8.58e-05	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.91e-06	8.55e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PTEN—malignant glioma	8.84e-06	8.48e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—SPHK1—malignant glioma	8.75e-06	8.38e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CAT—malignant glioma	8.71e-06	8.35e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PIK3CD—malignant glioma	8.65e-06	8.29e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PIK3CD—malignant glioma	8.57e-06	8.22e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.57e-06	8.21e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PIK3CB—malignant glioma	8.57e-06	8.21e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.55e-06	8.2e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PTGS2—malignant glioma	8.49e-06	8.14e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.47e-06	8.12e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PTGS1—malignant glioma	8.41e-06	8.07e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.38e-06	8.04e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PTEN—malignant glioma	8.23e-06	7.89e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—NCOR1—malignant glioma	8.22e-06	7.88e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PIK3CB—malignant glioma	8.14e-06	7.81e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.1e-06	7.77e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PTGS2—malignant glioma	8.07e-06	7.73e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GSTP1—malignant glioma	7.99e-06	7.66e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CAV1—malignant glioma	7.92e-06	7.59e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—STAT3—malignant glioma	7.91e-06	7.58e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—BCHE—malignant glioma	7.82e-06	7.5e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GSTP1—malignant glioma	7.8e-06	7.47e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CAT—malignant glioma	7.77e-06	7.45e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CAV1—malignant glioma	7.76e-06	7.43e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CAV1—malignant glioma	7.74e-06	7.42e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—SLC5A5—malignant glioma	7.73e-06	7.41e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CAT—malignant glioma	7.59e-06	7.27e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PIK3CB—malignant glioma	7.54e-06	7.23e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PIK3CB—malignant glioma	7.47e-06	7.16e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PTGS2—malignant glioma	7.47e-06	7.16e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PTGS2—malignant glioma	7.41e-06	7.1e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PTEN—malignant glioma	7.4e-06	7.1e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.39e-06	7.08e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—MYC—malignant glioma	7.35e-06	7.04e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GSTP1—malignant glioma	7.35e-06	7.04e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—NCOR1—malignant glioma	7.34e-06	7.04e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.31e-06	7e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GSTP1—malignant glioma	7.28e-06	6.98e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.24e-06	6.94e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.21e-06	6.91e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—EGFR—malignant glioma	7.19e-06	6.89e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—NCOR1—malignant glioma	7.16e-06	6.87e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CAT—malignant glioma	7.15e-06	6.85e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CAT—malignant glioma	7.09e-06	6.79e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PIK3CG—malignant glioma	7.06e-06	6.77e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.05e-06	6.76e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PTEN—malignant glioma	7.04e-06	6.75e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PPARG—malignant glioma	6.96e-06	6.67e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GSTT1—malignant glioma	6.93e-06	6.64e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PPARG—malignant glioma	6.82e-06	6.54e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PPARG—malignant glioma	6.8e-06	6.52e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—KRAS—malignant glioma	6.79e-06	6.51e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—NCOR1—malignant glioma	6.75e-06	6.47e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CAV1—malignant glioma	6.7e-06	6.43e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NCOR1—malignant glioma	6.69e-06	6.42e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PTEN—malignant glioma	6.52e-06	6.25e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PTGS1—malignant glioma	6.49e-06	6.22e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PTEN—malignant glioma	6.46e-06	6.19e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.4e-06	6.14e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.34e-06	6.08e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.31e-06	6.05e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PIK3CA—malignant glioma	6.24e-06	5.98e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GSTP1—malignant glioma	6.22e-06	5.97e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PIK3CD—malignant glioma	6.21e-06	5.95e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.2e-06	5.94e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PIK3CG—malignant glioma	6.11e-06	5.85e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CAT—malignant glioma	6.06e-06	5.81e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—BCHE—malignant glioma	6.04e-06	5.79e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CAV1—malignant glioma	5.98e-06	5.74e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.96e-06	5.72e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PPARG—malignant glioma	5.89e-06	5.65e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CAV1—malignant glioma	5.84e-06	5.6e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PIK3CA—malignant glioma	5.8e-06	5.56e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NCOR1—malignant glioma	5.72e-06	5.48e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.72e-06	5.48e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.53e-06	5.3e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CAV1—malignant glioma	5.5e-06	5.28e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PTGS2—malignant glioma	5.48e-06	5.25e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CAV1—malignant glioma	5.46e-06	5.23e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.45e-06	5.22e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PIK3CB—malignant glioma	5.41e-06	5.19e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PIK3CB—malignant glioma	5.4e-06	5.18e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PIK3CD—malignant glioma	5.37e-06	5.15e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PTGS2—malignant glioma	5.36e-06	5.14e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PTGS2—malignant glioma	5.35e-06	5.13e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PIK3CG—malignant glioma	5.32e-06	5.1e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PPARG—malignant glioma	5.26e-06	5.04e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PIK3CA—malignant glioma	5.22e-06	5.01e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.21e-06	5e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PPARG—malignant glioma	5.13e-06	4.92e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—AKT1—malignant glioma	5.1e-06	4.88e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.01e-06	4.81e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.97e-06	4.76e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PIK3CA—malignant glioma	4.96e-06	4.76e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PPARG—malignant glioma	4.84e-06	4.64e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GSTP1—malignant glioma	4.8e-06	4.6e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PPARG—malignant glioma	4.8e-06	4.6e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.79e-06	4.59e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PTEN—malignant glioma	4.78e-06	4.58e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—AKT1—malignant glioma	4.74e-06	4.55e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.68e-06	4.49e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PTEN—malignant glioma	4.68e-06	4.48e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PIK3CD—malignant glioma	4.68e-06	4.48e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CAT—malignant glioma	4.67e-06	4.48e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PTEN—malignant glioma	4.67e-06	4.47e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CAV1—malignant glioma	4.66e-06	4.47e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PTGS2—malignant glioma	4.64e-06	4.44e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PIK3CA—malignant glioma	4.6e-06	4.41e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.56e-06	4.37e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.45e-06	4.27e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NCOR1—malignant glioma	4.41e-06	4.23e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.41e-06	4.22e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.37e-06	4.19e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—AKT1—malignant glioma	4.27e-06	4.09e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.25e-06	4.07e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.18e-06	4e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PTGS2—malignant glioma	4.14e-06	3.97e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PPARG—malignant glioma	4.1e-06	3.93e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PIK3CB—malignant glioma	4.08e-06	3.91e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—AKT1—malignant glioma	4.06e-06	3.89e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PTEN—malignant glioma	4.04e-06	3.88e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PTGS2—malignant glioma	4.04e-06	3.87e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.84e-06	3.68e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.81e-06	3.65e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PTGS2—malignant glioma	3.81e-06	3.65e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PTGS2—malignant glioma	3.77e-06	3.62e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—AKT1—malignant glioma	3.75e-06	3.6e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.73e-06	3.58e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—AKT1—malignant glioma	3.72e-06	3.57e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PTEN—malignant glioma	3.61e-06	3.46e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CAV1—malignant glioma	3.6e-06	3.45e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PTEN—malignant glioma	3.52e-06	3.38e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.37e-06	3.23e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PTEN—malignant glioma	3.32e-06	3.18e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.3e-06	3.16e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.29e-06	3.16e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PTEN—malignant glioma	3.29e-06	3.15e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.28e-06	3.14e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.25e-06	3.12e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PTGS2—malignant glioma	3.22e-06	3.09e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PPARG—malignant glioma	3.16e-06	3.03e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.88e-06	2.76e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.85e-06	2.73e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PTEN—malignant glioma	2.81e-06	2.7e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—AKT1—malignant glioma	2.75e-06	2.64e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—AKT1—malignant glioma	2.7e-06	2.58e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—AKT1—malignant glioma	2.69e-06	2.58e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.55e-06	2.44e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.51e-06	2.41e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PTGS2—malignant glioma	2.49e-06	2.39e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PIK3CA—malignant glioma	2.49e-06	2.38e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.34e-06	2.24e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—AKT1—malignant glioma	2.33e-06	2.23e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.32e-06	2.23e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PTEN—malignant glioma	2.17e-06	2.08e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—AKT1—malignant glioma	2.08e-06	1.99e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—AKT1—malignant glioma	2.03e-06	1.95e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.98e-06	1.9e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—AKT1—malignant glioma	1.91e-06	1.83e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—AKT1—malignant glioma	1.9e-06	1.82e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—AKT1—malignant glioma	1.62e-06	1.55e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.53e-06	1.47e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—AKT1—malignant glioma	1.25e-06	1.2e-05	CbGpPWpGaD
